BCX17725

· BioCryst Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCX17725, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 [Phase 1]